NCT04735978 2026-02-27Study of RP3 Monotherapy and RP3 in Combination With Nivolumab in Patients With Solid TumoursReplimune Inc.Phase 1 Active not recruiting123 enrolled
NCT05163041 2026-01-15Study BT7480-100 in Patients With Advanced Malignancies Associated With Nectin-4 ExpressionBicycleTx LimitedPhase 1/2 Active not recruiting200 enrolled